BioPharma Pharma QC
Luye Pharma Licenses Rivastigmine Patch to Myung In Pharm for South Korea Commercialization
The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...
February 06, 2024 | News
Glenmark, Jiangsu Alphamab, and 3D Medicines Ink Global License Deal for Envafolimab (KN035)
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...
January 26, 2024 | News
Molecule AI Spearheads Pharmaceutical Transformation with AI-Driven Drug Discovery Innovations
Molecule AI, on a mission to accelerate drug discovery through the innovative use of artificial intelligence, is making significant...
January 20, 2024 | News
Mundipharma Greenlights European Approval for REZZAYO® in Treating Adult Invasive Candidiasis
The approval is based on the positive results of the pivotal Phase III ReSTORE clinical trial and is supported by STRIVE's Phase II clinical trials and a...
January 01, 2024 | News
Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager
The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...
January 01, 2024 | News
NOW tested over thirty Berberine supplements after surveying the online marketplace for questionable products.
Goldenseal is one well-known example of a berberine-rich plant and enjoys a long history of medicinal use by Native American tribes. Berberine has rece...
December 27, 2023 | News
Astellas Completes Acquisition of Propella Therapeutics
Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...
December 22, 2023 | News
Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index
In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...
December 15, 2023 | News
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...
December 07, 2023 | News
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant
Leading GMP cell CDMO I Peace, Inc. , specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that its&...
December 07, 2023 | News
Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA
Daewoong Pharmaceutical, represented by CEO Seng-ho Jeon and Chang-Jae Lee, proudly announced that their Osong factory passed the Brazilian Good Manuf...
November 28, 2023 | News
Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.
Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...
November 24, 2023 | News
WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale
By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...
November 23, 2023 | News
Merck Debuts ChemisTwin™: Digital Reference Materials Platform
Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials Allows Pharma QC/QA and R&...
November 16, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
